BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7544524)

  • 1. Primary T cell CD30-positive anaplastic large-cell lymphoma associated with adult-onset celiac disease and presenting with skin lesions.
    Mantovani G; Esu S; Astara G; Lampis B; Macciò A; Usai P; Santa Cruz G; Mura E; Ferreli A
    Acta Haematol; 1995; 94(1):48-51. PubMed ID: 7544524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ki-1-positive anaplastic large-cell lymphoma can mimic benign dermatoses.
    Camisa C; Helm TN; Sexton C; Tuthill R
    J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):696-700. PubMed ID: 8227541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 16-year experience at M. D. Anderson Cancer Center with primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large cell lymphoma.
    Romaguera JE; Garcia-Foncillas J; Cabanillas F
    Leuk Lymphoma; 1995 Dec; 20(1-2):97-102. PubMed ID: 8750629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: primary CD30 (Ki-1)-positive anaplastic large cell lymphoma of the duodenum.
    Yoshikawa I; Murata I; Tanaka Y; Kanagawa K; Tabaru A; Itoh H; Otsuki M
    Dig Dis Sci; 1996 Dec; 41(12):2343-7. PubMed ID: 9011440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ki-1-positive large-cell anaplastic lymphoma with protean manifestations including central nervous system involvement.
    Tsukamoto N; Morita K; Maehara T; Mitsuhashi M; Karasawa M; Murakami H; Omine M; Naruse T; Yatabe H
    Acta Haematol; 1992; 88(2-3):147-50. PubMed ID: 1334610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic features and treatment outcome of children with large-cell lymphoma and the t(2;5)(p23;q35).
    Sandlund JT; Pui CH; Roberts WM; Santana VM; Morris SW; Berard CW; Hutchison RE; Ribeiro RC; Mahmoud H; Crist WM
    Blood; 1994 Oct; 84(8):2467-71. PubMed ID: 7919366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Large cell anaplastic Ki-1 positive lymphoma of the skin. 5 personal cases and review of the literature].
    Trautmann C; Hahnemann HG; Hilbert ET; Detmar M; Gollnick H; Orfanos CE
    Hautarzt; 1995 Jan; 46(1):28-34. PubMed ID: 7875968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome.
    Shulman LN; Frisard B; Antin JH; Wheeler C; Pinkus G; Magauran N; Mauch P; Nobles E; Mashal R; Canellos G
    J Clin Oncol; 1993 May; 11(5):937-42. PubMed ID: 8387578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence with histological transformation 40 days after autologous peripheral blood stem cell transplantation (APBSCT) for cutaneous CD30-negative large T cell lymphoma.
    Nishio M; Sawada K; Koizumi K; Tarumi T; Takano H; Endo T; Takashima H; Hashimoto H; Haseyama Y; Kobayashi H; Koike T
    Bone Marrow Transplant; 1998 Dec; 22(12):1211-4. PubMed ID: 9894726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD30-positive cutaneous anaplastic large cell lymphoma with ichthyosis acquisita.
    Zamolo G; Gruber F; Bosner A; Cabrijan L; Petković M; Jonjić N
    Tumori; 1999; 85(1):71-4. PubMed ID: 10228503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of CD30 expression to survival and morphology in large cell B cell lymphomas.
    Noorduyn LA; de Bruin PC; van Heerde P; van de Sandt MM; Ossenkoppele GJ; Meijer CJ
    J Clin Pathol; 1994 Jan; 47(1):33-7. PubMed ID: 8132806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone involvement and abcess formation by neutrophil-rich CD30+ anaplastic large-cell lymphoma mimicking skeletal infection in an AIDS patient.
    Mira JA; Fernández-Alonso J; Macías J; Sáez C; Japón MA; Pereda T; Pineda JA
    J Infect; 2003 Jul; 47(1):73-6. PubMed ID: 12850166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients.
    Bekkenk MW; Vermeer MH; Jansen PM; van Marion AM; Canninga-van Dijk MR; Kluin PM; Geerts ML; Meijer CJ; Willemze R
    Blood; 2003 Sep; 102(6):2213-9. PubMed ID: 12750155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD30 expression and prognostic significance in R-EPOCH-treated patients with diffuse large B-cell lymphoma.
    Xu J; Oki Y; Saksena A; Desai P; Lin P; Tang G; Yin CC; You MJ; Thakral B; Medeiros LJ; Li S
    Hum Pathol; 2017 Feb; 60():160-166. PubMed ID: 27816715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A unique atrial primary cardiac lymphoma mimicking myxoma presenting with embolic stroke: a case report.
    Quigley MM; Schwartzman E; Boswell PD; Christensen RL; Gleason LA; Sharpe RW; D'Amato TA
    Blood; 2003 Jun; 101(12):4708-10. PubMed ID: 12560231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptomeningeal seeding with acute hydrocephalus--unusual central nervous system presentation during chemotherapy in Ki-1-positive anaplastic large-cell lymphoma.
    Chen HS; Shen MC; Tien HF; Su IJ; Wang CH
    Acta Haematol; 1996; 95(2):135-9. PubMed ID: 8638443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Herpesvirus Type 8-associated Large B-cell Lymphoma: A Nonserous Extracavitary Variant of Primary Effusion Lymphoma in an HIV-infected Man: A Case Report and Review of the Literature.
    Foster WR; Bischin A; Dorer R; Aboulafia DM
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):311-21. PubMed ID: 27234438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should primary cutaneous Ki-1(CD30)-positive anaplastic large cell lymphoma in childhood be treated with multiple-agent chemotherapy?
    Vermeer MH; Bekkenk MW; Willemze R
    J Am Acad Dermatol; 2001 Oct; 45(4):638-40. PubMed ID: 11568767
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary cutaneous diffuse large B-cell lymphoma (leg type) after renal allograft.
    Zhao J; Han B; Shen T; Zhao Y; Wang T; Liu Y; Fang K
    Eur J Haematol; 2008 Aug; 81(2):163. PubMed ID: 18363873
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites.
    Wang C; Li W; Liu C; He H; Bai O
    Blood Cells Mol Dis; 2016 Mar; 57():42-9. PubMed ID: 26852654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.